NAD Intervention Prevents Dietary Supplement Manufacturer From Making Unsubstantiated Ad Campaigns

Following the intervention of a consumer watchdog group, one dietary supplement manufacturer has agreed to stop perpetuating unsubstantiated claims about their products. Subsequently, the National Advertising Division of the Council of Better Business Bureaus recommended that Barlow Herbal Specialities discontinue their current ad campaign that suggests LDM-100 is a “plant or herb antibiotic” for fear that fraudulent advertising may cause consumers to forgo necessary medical intervention. Dietary supplements may not be advertised to diagnose, treat, cure or prevent any disease as clarified in the Dietary Supplement Health and Education Act of 1994.

LDM-100 is a derivative of Lomatium dissectum, a plant indigenous to the eastern slopes of the Sierra Nevada Mountains. Scientific investigation of the plant reveals that the volatile oil factions in the root contain what researchers believe to be an anti-viral/antibiotic ingredient. Further investigation revealed potentially powerful anti-bacterial/anti-fungal properties. The Lomatium dissectum extract is believed to have a viro-static effect, meaning that it may stop the growth of viruses, bacteria and fungus in the body. Subsequently, the body’s natural immune system may then eliminate the lethal micro-organisms without harming those deemed beneficial.

Touted as the next generation in antibiotic herbs, LDM-100 is a dietary supplement with allegedly limitless potential. Advertising campaigns suggest that LDM-100 is a broad spectrum plant antibiotic that exhibits the properties of virastatic, bacteriostatic, and fungicidal compounds. According to claims made by Barlow Herbal Specialities, LDM-100 is a dietary supplement capable of assisting in the treatment of influenza, colds, respiratory and urinary infections, staph and strep infections, difficult viral infections, lansing, polio, E.B. infections, fungus infection, skin infection, and warts.

However, claims such as these are in direct violation of the Dietary Supplement Health and Education Act of 1994. According to the act, dietary supplements may not be advertised to diagnose, treat, cure or prevent any disease. As a resutlt, the National Advertising Division has requested the substantiation of Barlow Herbal’s claims.

The National Advertising Division is “very concerned that the advertising may cause consumers to forgo medical treatment for their virastatic, bacteriostatic and fungicidal infections” given that the current ad campaign suggests ‘that LDM-100 preforms like a pharmaceutical grade antibiotic.”

Accordingly, Barlow Herbal Specialities has agreed to remove ad campaigns suggesting that LDM-100 exhibits antibiotic properties.

Do I Have an LDM-100 Lawsuit?

The trial lawyers at The Senators (Ret.) Firm, LLP have decades of experience navigating through complex legislative and regulatory issues and litigating high stakes cases all over the nation. Our law firm focuses on the representation of plaintiffs in LDM-100 lawsuits. We are currently accepting new cases in all 50 states.

If you or a loved one has been injured by LDM-100, you may be entitled to financial compensation. For a free case review, please click the link below or call toll free 24 hrs/day 1-(949) 557-5800.